On Oct. 13, GitLab (NASDAQ:GTLB) had a successful IPO, with the stock priced at $77 per share. Now almost a month later, GTLB stock is now at $121.27. So, virtually everyone who bought in around the time of the IPO has made money. Source: Lori Butcher / Shutterstock.com The problem is there is no more
Daily Trade
The co-founder and former chief of MoviePass Inc. is getting ready to test whether the popular — though failed — theater subscription service can return for a sequel with a new business model. Stacy Spikes, now helming a company called PreTechnology Inc., intends to test a revised business strategy during the busy holiday season between
C3.ai (NYSE:AI) has had a seriously underwhelming 2021; AI stock has dropped more than 60% year-to-date. That said, most of the damage was done in the spring, when shares tumbled from $120 to $50. Since then, AI stock has moved in a trading range as investors wait for new developments from the firm to reset
Shares of Walt Disney Co. dove toward an 11-month low Thursday, as multiple analysts cut price their price targets, even the bullish ones, in response to the media and theme-park giant’s disappointing earnings and outlook for Disney+ subscribers. But Wall Street remained overwhelmingly bullish on Disney’s prospects, highlighting the expected continued rebounds in the company’s
Gores Guggenheim (NASDAQ:GGPI) is the latest SPAC (Special Purpose Acquisition Company) stock to start revving its carbon-free engine. The blank check company completed its initial public offering (IPO) in March and announced its reverse merger with Electric Vehicle (EV) maker Polestar in September. GGPI shares are now trading at a roughly 7% premium to trust
Planning a trip to visit family for the holidays this year? You won’t be alone — and that makes the potential for widespread flight delays and cancellations all the more likely. With nearly 200 million Americans vaccinated against the virus that causes COVID-19 and the delta variant receding, many more people are feeling comfortable taking
It’s no shock Greenidge Generation (NASDAQ:GREE) has been bouncing back lately. After all, bullish sentiment is returning to GREE stock now that Bitcoin (CCC:BTC-USD), the crypto it mines, is up near all-time highs. But there’s also a longer-term catalyst that GREE fans have high hopes about: Its expansion plans. Source: Mark Agnor / Shutterstock.com GREE’s latest success
How Much of GE’s Business Is Healthcare, Aviation and Energy? General Electric Co. once sprawled across 13 industries, including insurance, plastics and even media. Here is a visualization of the changes, merges and splits that led to GE’s plan to become three public companies. Nov. 10, 2021 at 10:51 a.m. ET by Elliot Bentley
So long as investors are only buying growth, CrowdStrike (NASDAQ:CRWD) stock should keep performing. Source: VDB Photos / Shutterstock.com Even so, its market cap, which is more than 50 times revenue, is ridiculous. CrowdStrike, a cybersecurity company, opened for trade Nov. 9 at $285.68 share. The market cap at that price is $65.22 billion. The expected
Electric-vehicle maker Rivian Automotive Inc. is set to become a public company, hoping to carve a niche for itself offering EVs for the great outdoors. Rivian RIVN filed for a confidential IPO in August and priced its shares at $78 each Tuesday night — well higher than their already-elevated range of $72 to $74 a
In 2021, biopharmaceutical company Ocugen (NASDAQ:OCGN) has been a paradise for well-timed, short-term traders. On the other hand, long-term OCGN stock investors have been through a virtual roller-coaster ride. Source: shutterstock.com/PhotobyTawat As we’ll see, the stock has well-defined support and resistance levels. Swing traders could potentially profit (no guarantees, of course) from a simple rinse-and-repeat strategy.
U.S. stock indexes were facing selling pressure midday Tuesday, giving up slight early gains, with the Nasdaq Composite and S&P 500 losing their grip on their longest win streaks in more than two years. Investors were parsing a report on U.S. wholesale inflation and news that industrial conglomerate General Electric was planning on splitting into
Canadian marijuana producer and processor Tilray (NASDAQ:TLRY) made history in July 2018 when it became the first pure-play cannabis company to trade publicly on a major U.S. exchange. Just three months later, the Canadian government legalized marijuana for recreational purposes, in addition to the already legalized medical use. TLRY stock, which went public at $17
The total cryptocurrency market topped $3 trillion Monday, for the first time, according to data from CoinGecko. Market capitalization of the crypto market has gained more than 280% since the start of this year. That rally for crypto has been at least partly fueled by a run-up in Ethereum, which climbed to a record high
I like Amazon (NASDAQ:AMZN) stock. I don’t think a week goes by when there’s not an Amazon delivery coming to my house, and I know my neighbors seem to be just as eager to shop on Amazon than I do. The delivery drivers know our street like the back of their hands at this point.
Federal Reserve Governor Randal Quarles said he will resign at the end of the December, leaving another vacant spot for the White House to fill and giving President Biden a chance to reshape the U.S. central bank. Quarles recently finished out his term as the Fed’s first-ever vice chairman of supervision of U.S. banks, a
The buy now, pay later (BNPL) market is red-hot, and related stocks are reaping the benefits or doubling down. Affirm Holdings (NASDAQ:AFRM) exploded from $50 to over $160 since May. Paidy was just acquired by PayPal (NASDAQ:PYPL) for $2.7 billion. Afterpay was acquired by Square (NYSE:SQ) in a $29 billion deal. Even Amazon (NASDAQ:AMZN), Target (NYSE:TGT)
Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of leukemia, the companies said. Of the total investment, as much as $150 million will support the development and commercialization of obecabtagene autoleucel, a cell therapy that
Although all eyes have been on the searing path that benchmark equity indices have blazed in 2021, initial public offerings (IPOs) have had their own impressive bull market. In fact, Reuters reported in mid-June that U.S. IPOs hit an annual record in less than six months. So if 2020 was the year of the novel
After Zillow Z, -2.12% ZG, -3.43% shocked investors by announcing that it would leave the business of buying and selling homes altogether — just weeks after the company initially indicated it was simply pausing its home-flipping efforts — myriad questions emerged. A central one has been whether the problems Zillow encountered were unique to its